Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir in heart failure with reduced ejection fraction
ChiCTR2100054764Phase 4Recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oseltamivir in heart failure with reduced ejection fraction (HFrEF) (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Six-minute walking distance. Started Mar 2021; status: recruiting.
02
Drugs
oseltamivir
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on ChiCTR2100054764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054764.